Overall Technical outlook

Price Summary

On 2026-04-09, JBCHEPHARM's stock started at 1943.5, reached a high of 1983.1, fell to 1943.5, and ended 1.37% up at 1970.2, with 341489 shares traded.
In the 52-week period, the stock's peak price is 2131.4, and the lowest price recorded is 0.0.
The expected price range is between 1752.0 and 2320.0, with a mean anticipated price of 2118.0908, according to 11 analysts.

Technicals

Support and Resistance: The price of 1970.2 is supported at 1933.0 and encounters resistance at 2081.4. This suggests key levels where the price might find stability, with 1933.0 providing a base and 2081.4 acting as an upper boundary for JBCHEPHARM.
JBCHEPHARM supportResistance 1832b9
Support/Resistance for JBCHEPHARM


Aroon: The AROON is showing a neutral stance, with no definitive indication of an upward or downward trend for JBCHEPHARM. This neutral position suggests a period of indecision in the market, making it difficult to predict the next move.
JBCHEPHARM aroon 1832b9
Aroon chart for J. B. Chemicals & Pharmaceuticals Limited


Bol. Bands: The current state of the BOLL BANDS is neutral, offering no clear signals of movement in either direction. This suggests a potential pause in market activity, with no strong trend emerging at the moment.
JBCHEPHARM bbands 1832b9
Bolinger Bands chart for J. B. Chemicals & Pharmaceuticals Limited


Parabolic SAR: The PSAR continues its bearish trend, setting a resistance level that could prevent significant upward movement for JBCHEPHARM. This resistance suggests that the market may struggle to overcome bearish forces, keeping upward momentum in check.
JBCHEPHARM psar 1832b9
Parabolic Stop and Reverse chart for J. B. Chemicals & Pharmaceuticals Limited


Stochastic: The STOCHASTIC is in a neutral stance, not pointing to a clear trend in either direction. This suggests that the market may be lacking strong momentum, making it difficult to predict the next move.
JBCHEPHARM stoch 1832b9
Stochastic chart for J. B. Chemicals & Pharmaceuticals Limited


Tripple Moving Agerage: The Tripple MOVING AVG is currently in a neutral position, offering no clear indication of movement up or down. This suggests that the market may be experiencing a period of equilibrium, with no strong trend in play.
JBCHEPHARM trippleSMA 1832b9
Tripple SMA chart for J. B. Chemicals & Pharmaceuticals Limited


Understanding a company's fundamentals—such as revenue, earnings, and debt levels—provides a solid foundation for analyzing its technical performance. Similarly, knowledge of the industry, including key competitors and market trends, is critical. Combining this fundamental analysis with technical indicators like stock charts, moving averages, and trading volume enables a more comprehensive approach to evaluating the company's overall health and potential future performance.